NEWS

Facebook Line

PEP07: A novel, brain penetrant oral Chk1 inhibitor for the treatment of AML and MCL (6th Annual DDR Inhibitors Summit 2023)

BACK TO NEWS

Contact

Chihsing Chang
Vice President, Finance and Administration
TEL +886 2 2515 8228, ext. 700
© 2018 PharmaEngine Inc.
Go To Top